Related Experiment Video
Updated: Jul 4, 2026
08:47
Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy
Published on: December 7, 2017
Diabetes: 1 and 2, or one and the same? Progress with the accelerator hypothesis
1Department of Endocrinology & Metabolism, Peninsula Medical School, Plymouth, Devon, UK. T.Wilkin@pms.ac.uk
Pediatric Diabetes
|June 11, 2008
Summary
The accelerator hypothesis suggests type 1 and type 2 diabetes stem from insulin resistance, with genetics influencing disease progression. Evidence shows age of onset inversely correlates with BMI, supporting this unified view of diabetes.
Area of Science:
- Endocrinology
- Metabolic Disorders
- Genetics
Background:
- The accelerator hypothesis (2001) posits type 1 and type 2 diabetes share a common insulin resistance mechanism.
- Genetic variations are proposed to modulate beta-cell loss rate, influencing disease onset and incidence.
Purpose of the Study:
- To update the accelerator hypothesis with new supporting evidence.
- To address challenges and counterarguments presented in scientific literature.
- To propose a clinical trial for testing a novel diabetes management principle.
Main Methods:
- Review and synthesis of existing data and published studies.
- Analysis of the relationship between Body Mass Index (BMI) and age of diabetes onset.
- Formulation of a randomized controlled trial design.
Main Results:
- Five independent studies confirm an inverse relationship between BMI and age of onset, supporting the hypothesis.
- The hypothesis's predictions are increasingly validated by new epidemiological and genetic data.
- Challenges to the hypothesis have been addressed with updated evidence.
Conclusions:
- The accelerator hypothesis provides a unifying framework for understanding type 1 and type 2 diabetes.
- Evidence supports the role of insulin resistance and genetic background in diabetes pathogenesis.
- A proposed trial aims to test glucose reduction's impact on beta-cell preservation and diabetes incidence.
Related Concept Videos
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...